APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumonia Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pneumonia Treatment Drugs Industry Research Report 2026

22 December 2025128 pages

Choose your research edition.

Industry ResearchPneumonia Treatment Drugs Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumonia Treatment Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pneumonia Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumonia Treatment Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumonia Treatment Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pneumonia Treatment Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pneumonia Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pneumonia Treatment Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pneumonia Treatment Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pneumonia Treatment Drugs include Teva Pharmaceutical, Sun Pharmaceutical, Novartis, Mylan, Pfizer, GlaxoSmithKline, AstraZeneca, Theravance Biopharma and Shinogi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pneumonia Treatment Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pneumonia Treatment Drugs Market by Company

Teva Pharmaceutical

Sun Pharmaceutical

Novartis

Mylan

Pfizer

GlaxoSmithKline

AstraZeneca

Theravance Biopharma

Shinogi

MSD

Medicines

Combioxin

Arsanis

Pneumonia Treatment Drugs Segment by Type

Vaccines

Vancomycin

Cephalosporin

Tetracyclines

Penicillin

Other Antibiotics

Immunotherapy Drug

Interferon

Fluoroquinolones

Macrolides

Pneumonia Treatment Drugs Segment by Application

Hospital

Clinic

Drugstore

Pneumonia Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumonia Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumonia Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumonia Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pneumonia Treatment Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pneumonia Treatment Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pneumonia Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pneumonia Treatment Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pneumonia Treatment Drugs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Pneumonia Treatment Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pneumonia Treatment Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Pneumonia Treatment Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pneumonia Treatment Drugs Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Pneumonia Treatment Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pneumonia Treatment Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pneumonia Treatment Drugs, Product Type & Application Table 14. Global Pneumonia Treatment Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pneumonia Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceutical Company Information Table 19. Teva Pharmaceutical Business Overview Table 20. Teva Pharmaceutical Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Teva Pharmaceutical Pneumonia Treatment Drugs Product Portfolio Table 22. Teva Pharmaceutical Recent Developments Table 23. Sun Pharmaceutical Company Information Table 24. Sun Pharmaceutical Business Overview Table 25. Sun Pharmaceutical Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sun Pharmaceutical Pneumonia Treatment Drugs Product Portfolio Table 27. Sun Pharmaceutical Recent Developments Table 28. Novartis Company Information Table 29. Novartis Business Overview Table 30. Novartis Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Novartis Pneumonia Treatment Drugs Product Portfolio Table 32. Novartis Recent Developments Table 33. Mylan Company Information Table 34. Mylan Business Overview Table 35. Mylan Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Mylan Pneumonia Treatment Drugs Product Portfolio Table 37. Mylan Recent Developments Table 38. Pfizer Company Information Table 39. Pfizer Business Overview Table 40. Pfizer Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Pfizer Pneumonia Treatment Drugs Product Portfolio Table 42. Pfizer Recent Developments Table 43. GlaxoSmithKline Company Information Table 44. GlaxoSmithKline Business Overview Table 45. GlaxoSmithKline Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. GlaxoSmithKline Pneumonia Treatment Drugs Product Portfolio Table 47. GlaxoSmithKline Recent Developments Table 48. AstraZeneca Company Information Table 49. AstraZeneca Business Overview Table 50. AstraZeneca Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. AstraZeneca Pneumonia Treatment Drugs Product Portfolio Table 52. AstraZeneca Recent Developments Table 53. Theravance Biopharma Company Information Table 54. Theravance Biopharma Business Overview Table 55. Theravance Biopharma Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Theravance Biopharma Pneumonia Treatment Drugs Product Portfolio Table 57. Theravance Biopharma Recent Developments Table 58. Shinogi Company Information Table 59. Shinogi Business Overview Table 60. Shinogi Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Shinogi Pneumonia Treatment Drugs Product Portfolio Table 62. Shinogi Recent Developments Table 63. MSD Company Information Table 64. MSD Business Overview Table 65. MSD Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. MSD Pneumonia Treatment Drugs Product Portfolio Table 67. MSD Recent Developments Table 68. Medicines Company Information Table 69. Medicines Business Overview Table 70. Medicines Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Medicines Pneumonia Treatment Drugs Product Portfolio Table 72. Medicines Recent Developments Table 73. Combioxin Company Information Table 74. Combioxin Business Overview Table 75. Combioxin Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Combioxin Pneumonia Treatment Drugs Product Portfolio Table 77. Combioxin Recent Developments Table 78. Arsanis Company Information Table 79. Arsanis Business Overview Table 80. Arsanis Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Arsanis Pneumonia Treatment Drugs Product Portfolio Table 82. Arsanis Recent Developments Table 83. Global Pneumonia Treatment Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Pneumonia Treatment Drugs Sales by Region (2021-2026) & (k units) Table 85. Global Pneumonia Treatment Drugs Sales Market Share by Region (2021-2026) Table 86. Global Pneumonia Treatment Drugs Sales by Region (2027-2032) & (k units) Table 87. Global Pneumonia Treatment Drugs Sales Market Share by Region (2027-2032) Table 88. Global Pneumonia Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Pneumonia Treatment Drugs Revenue Market Share by Region (2021-2026) Table 90. Global Pneumonia Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Pneumonia Treatment Drugs Revenue Market Share by Region (2027-2032) Table 92. North America Pneumonia Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 94. North America Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 95. North America Pneumonia Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Pneumonia Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Pneumonia Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 99. Europe Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 100. Europe Pneumonia Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Pneumonia Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Pneumonia Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 104. Asia Pacific Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 105. Asia Pacific Pneumonia Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Pneumonia Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Pneumonia Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 109. South America Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 110. South America Pneumonia Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Pneumonia Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Pneumonia Treatment Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 114. Middle East and Africa Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 115. Middle East and Africa Pneumonia Treatment Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Pneumonia Treatment Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Pneumonia Treatment Drugs Sales by Type (2021-2026) & (k units) Table 118. Global Pneumonia Treatment Drugs Sales by Type (2027-2032) & (k units) Table 119. Global Pneumonia Treatment Drugs Sales Market Share by Type (2021-2026) Table 120. Global Pneumonia Treatment Drugs Sales Market Share by Type (2027-2032) Table 121. Global Pneumonia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Pneumonia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Pneumonia Treatment Drugs Revenue Market Share by Type (2021-2026) Table 124. Global Pneumonia Treatment Drugs Revenue Market Share by Type (2027-2032) Table 125. Global Pneumonia Treatment Drugs Price by Type (2021-2026) & (US$/unit) Table 126. Global Pneumonia Treatment Drugs Price by Type (2027-2032) & (US$/unit) Table 127. Global Pneumonia Treatment Drugs Sales by Application (2021-2026) & (k units) Table 128. Global Pneumonia Treatment Drugs Sales by Application (2027-2032) & (k units) Table 129. Global Pneumonia Treatment Drugs Sales Market Share by Application (2021-2026) Table 130. Global Pneumonia Treatment Drugs Sales Market Share by Application (2027-2032) Table 131. Global Pneumonia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Pneumonia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Pneumonia Treatment Drugs Revenue Market Share by Application (2021-2026) Table 134. Global Pneumonia Treatment Drugs Revenue Market Share by Application (2027-2032) Table 135. Global Pneumonia Treatment Drugs Price by Application (2021-2026) & (US$/unit) Table 136. Global Pneumonia Treatment Drugs Price by Application (2027-2032) & (US$/unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Pneumonia Treatment Drugs Distributors List Table 140. Pneumonia Treatment Drugs Customers List Table 141. Pneumonia Treatment Drugs Industry Trends Table 142. Pneumonia Treatment Drugs Industry Drivers Table 143. Pneumonia Treatment Drugs Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pneumonia Treatment Drugs Product Image Figure 5. Global Pneumonia Treatment Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pneumonia Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Pneumonia Treatment Drugs Sales (2021-2032) & (k units) Figure 8. Global Pneumonia Treatment Drugs Average Price (US$/unit) & (2021-2032) Figure 9. Vaccines Product Image Figure 10. Vancomycin Product Image Figure 11. Cephalosporin Product Image Figure 12. Tetracyclines Product Image Figure 13. Penicillin Product Image Figure 14. Other Antibiotics Product Image Figure 15. Immunotherapy Drug Product Image Figure 16. Interferon Product Image Figure 17. Fluoroquinolones Product Image Figure 18. Macrolides Product Image Figure 19. Hospital Product Image Figure 20. Clinic Product Image Figure 21. Drugstore Product Image Figure 22. Global Pneumonia Treatment Drugs Revenue Share by Manufacturers in 2025 Figure 23. Global Manufacturers of Pneumonia Treatment Drugs, Manufacturing Sites & Headquarters Figure 24. Global Top 5 and 10 Pneumonia Treatment Drugs Players Market Share by Revenue in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Pneumonia Treatment Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 27. Global Pneumonia Treatment Drugs Sales by Region in 2025 Figure 28. Global Pneumonia Treatment Drugs Revenue by Region in 2025 Figure 29. North America Pneumonia Treatment Drugs Market Size by Country in 2025 Figure 30. North America Pneumonia Treatment Drugs Sales Market Share by Country (2021-2032) Figure 31. North America Pneumonia Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 32. United States Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Mexico Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Europe Pneumonia Treatment Drugs Market Size by Country in 2025 Figure 36. Europe Pneumonia Treatment Drugs Sales Market Share by Country (2021-2032) Figure 37. Europe Pneumonia Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 38. Germany Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. France Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. U.K. Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Italy Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Russia Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Spain Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Netherlands Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Switzerland Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Sweden Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Poland Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Asia Pacific Pneumonia Treatment Drugs Market Size by Country in 2025 Figure 49. Asia Pacific Pneumonia Treatment Drugs Sales Market Share by Country (2021-2032) Figure 50. Asia Pacific Pneumonia Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 51. China Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Japan Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South Korea Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. India Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Australia Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Taiwan Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Southeast Asia Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Southeast Asia Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. South America Pneumonia Treatment Drugs Market Size by Country in 2025 Figure 60. South America Pneumonia Treatment Drugs Sales Market Share by Country (2021-2032) Figure 61. South America Pneumonia Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 62. Brazil Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Argentina Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Chile Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Middle East and Africa Pneumonia Treatment Drugs Market Size by Country in 2025 Figure 66. Middle East and Africa Pneumonia Treatment Drugs Sales Market Share by Country (2021-2032) Figure 67. Middle East and Africa Pneumonia Treatment Drugs Revenue Market Share by Country (2021-2032) Figure 68. Egypt Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. South Africa Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Israel Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Türkiye Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 72. GCC Countries Pneumonia Treatment Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 73. Global Pneumonia Treatment Drugs Sales Market Share by Type (2021-2032) Figure 74. Global Pneumonia Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 75. Global Pneumonia Treatment Drugs Price (US$/unit) by Type (2021-2032) Figure 76. Global Pneumonia Treatment Drugs Sales Market Share by Application (2021-2032) Figure 77. Global Pneumonia Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 78. Global Pneumonia Treatment Drugs Price (US$/unit) by Application (2021-2032) Figure 79. Pneumonia Treatment Drugs Value Chain Figure 80. Pneumonia Treatment Drugs Production Mode & Process Figure 81. Direct Comparison with Distribution Share Figure 82. Distributors Profiles Figure 83. Pneumonia Treatment Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Vaccines
  • Vancomycin
  • Cephalosporin
  • Tetracyclines
  • Penicillin
  • Other Antibiotics
  • Immunotherapy Drug
  • Interferon
  • Fluoroquinolones
  • Macrolides
Applications
  • Hospital
  • Clinic
  • Drugstore
Companies covered
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Novartis
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Theravance Biopharma
  • Shinogi
  • MSD
  • Medicines
  • Combioxin
  • Arsanis

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pneumonia Treatment Drugs Market Size (2021-2032)
  4. 2.2.2 Global Pneumonia Treatment Drugs Sales (2021-2032)
  5. 2.2.3 Global Pneumonia Treatment Drugs Market Average Price (2021-2032)
  6. 2.3 Pneumonia Treatment Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Vaccines
  9. 2.3.3 Vancomycin
  10. 2.3.4 Cephalosporin
  11. 2.3.5 Tetracyclines
  12. 2.3.6 Penicillin
  13. 2.3.7 Other Antibiotics
  14. 2.3.8 Immunotherapy Drug
  15. 2.3.9 Interferon
  16. 2.3.10 Fluoroquinolones
  17. 2.3.11 Macrolides
  18. 2.4 Pneumonia Treatment Drugs by Application
  19. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  20. 2.4.2 Hospital
  21. 2.4.3 Clinic
  22. 2.4.4 Drugstore
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pneumonia Treatment Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pneumonia Treatment Drugs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Pneumonia Treatment Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pneumonia Treatment Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pneumonia Treatment Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pneumonia Treatment Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pneumonia Treatment Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Pneumonia Treatment Drugs, Established Date
  9. 3.9 Global Pneumonia Treatment Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceutical
  2. 4.1.1 Teva Pharmaceutical Company Information
  3. 4.1.2 Teva Pharmaceutical Business Overview
  4. 4.1.3 Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceutical Pneumonia Treatment Drugs Product Portfolio
  6. 4.1.5 Teva Pharmaceutical Recent Developments
  7. 4.2 Sun Pharmaceutical
  8. 4.2.1 Sun Pharmaceutical Company Information
  9. 4.2.2 Sun Pharmaceutical Business Overview
  10. 4.2.3 Sun Pharmaceutical Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sun Pharmaceutical Pneumonia Treatment Drugs Product Portfolio
  12. 4.2.5 Sun Pharmaceutical Recent Developments
  13. 4.3 Novartis
  14. 4.3.1 Novartis Company Information
  15. 4.3.2 Novartis Business Overview
  16. 4.3.3 Novartis Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novartis Pneumonia Treatment Drugs Product Portfolio
  18. 4.3.5 Novartis Recent Developments
  19. 4.4 Mylan
  20. 4.4.1 Mylan Company Information
  21. 4.4.2 Mylan Business Overview
  22. 4.4.3 Mylan Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mylan Pneumonia Treatment Drugs Product Portfolio
  24. 4.4.5 Mylan Recent Developments
  25. 4.5 Pfizer
  26. 4.5.1 Pfizer Company Information
  27. 4.5.2 Pfizer Business Overview
  28. 4.5.3 Pfizer Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pfizer Pneumonia Treatment Drugs Product Portfolio
  30. 4.5.5 Pfizer Recent Developments
  31. 4.6 GlaxoSmithKline
  32. 4.6.1 GlaxoSmithKline Company Information
  33. 4.6.2 GlaxoSmithKline Business Overview
  34. 4.6.3 GlaxoSmithKline Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GlaxoSmithKline Pneumonia Treatment Drugs Product Portfolio
  36. 4.6.5 GlaxoSmithKline Recent Developments
  37. 4.7 AstraZeneca
  38. 4.7.1 AstraZeneca Company Information
  39. 4.7.2 AstraZeneca Business Overview
  40. 4.7.3 AstraZeneca Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 AstraZeneca Pneumonia Treatment Drugs Product Portfolio
  42. 4.7.5 AstraZeneca Recent Developments
  43. 4.8 Theravance Biopharma
  44. 4.8.1 Theravance Biopharma Company Information
  45. 4.8.2 Theravance Biopharma Business Overview
  46. 4.8.3 Theravance Biopharma Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Theravance Biopharma Pneumonia Treatment Drugs Product Portfolio
  48. 4.8.5 Theravance Biopharma Recent Developments
  49. 4.9 Shinogi
  50. 4.9.1 Shinogi Company Information
  51. 4.9.2 Shinogi Business Overview
  52. 4.9.3 Shinogi Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Shinogi Pneumonia Treatment Drugs Product Portfolio
  54. 4.9.5 Shinogi Recent Developments
  55. 4.10 MSD
  56. 4.10.1 MSD Company Information
  57. 4.10.2 MSD Business Overview
  58. 4.10.3 MSD Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 MSD Pneumonia Treatment Drugs Product Portfolio
  60. 4.10.5 MSD Recent Developments
  61. 4.11 Medicines
  62. 4.11.1 Medicines Company Information
  63. 4.11.2 Medicines Business Overview
  64. 4.11.3 Medicines Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Medicines Pneumonia Treatment Drugs Product Portfolio
  66. 4.11.5 Medicines Recent Developments
  67. 4.12 Combioxin
  68. 4.12.1 Combioxin Company Information
  69. 4.12.2 Combioxin Business Overview
  70. 4.12.3 Combioxin Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Combioxin Pneumonia Treatment Drugs Product Portfolio
  72. 4.12.5 Combioxin Recent Developments
  73. 4.13 Arsanis
  74. 4.13.1 Arsanis Company Information
  75. 4.13.2 Arsanis Business Overview
  76. 4.13.3 Arsanis Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Arsanis Pneumonia Treatment Drugs Product Portfolio
  78. 4.13.5 Arsanis Recent Developments
5 Global Pneumonia Treatment Drugs Market Scenario by Region
  1. 5.1 Global Pneumonia Treatment Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pneumonia Treatment Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Pneumonia Treatment Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Pneumonia Treatment Drugs Sales by Region: 2027-2032
  5. 5.3 Global Pneumonia Treatment Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Pneumonia Treatment Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Pneumonia Treatment Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Pneumonia Treatment Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Pneumonia Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pneumonia Treatment Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Pneumonia Treatment Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pneumonia Treatment Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Pneumonia Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pneumonia Treatment Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Pneumonia Treatment Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pneumonia Treatment Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pneumonia Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pneumonia Treatment Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pneumonia Treatment Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pneumonia Treatment Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Pneumonia Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pneumonia Treatment Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Pneumonia Treatment Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pneumonia Treatment Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pneumonia Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pneumonia Treatment Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pneumonia Treatment Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pneumonia Treatment Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Pneumonia Treatment Drugs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Pneumonia Treatment Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pneumonia Treatment Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Pneumonia Treatment Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pneumonia Treatment Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pneumonia Treatment Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pneumonia Treatment Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Pneumonia Treatment Drugs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Pneumonia Treatment Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pneumonia Treatment Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Pneumonia Treatment Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pneumonia Treatment Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pneumonia Treatment Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pneumonia Treatment Drugs Value Chain Analysis
  2. 8.1.1 Pneumonia Treatment Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pneumonia Treatment Drugs Production Mode & Process
  5. 8.2 Pneumonia Treatment Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pneumonia Treatment Drugs Distributors
  8. 8.2.3 Pneumonia Treatment Drugs Customers
9 Global Pneumonia Treatment Drugs Analyzing Market Dynamics
  1. 9.1 Pneumonia Treatment Drugs Industry Trends
  2. 9.2 Pneumonia Treatment Drugs Industry Drivers
  3. 9.3 Pneumonia Treatment Drugs Industry Opportunities and Challenges
  4. 9.4 Pneumonia Treatment Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst